Interview with Mary-Claire King, author of Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women

Interview with Monica Morrow, MD, author of Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management

Interview with Martin G. Sanda, MD, author of Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer

Interview with Arvind Dasari, MD, author of Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Interview with Hazel B. Nichols, PhD, author of Birth Outcomes Among Adolescent and Young Adult Cancer Survivors

Interview with Ethan M. Basch, MD, MSc, author of Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Interview with Daniel Joseph. Boffa, MD, author of Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery

Interview with Christina Fitzmaurice, MD, MPH, author of Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study

Interview with Michelle E. Melisko, MD, author of Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial

Interview with Kevin T. Nead, MD, MPhil, author of Association Between Androgen Deprivation Therapy and Risk of Dementia

Interview with Gretchen L. Gierach, PhD, author of Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting

Interview with Conny Vrieling, MD PhD, author of Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

Interview with Razelle Kurzrock, MD, author of Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis

Interview with Smita Bhatia, MD, MPH, author of Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study

Interview with Mingyang Song, MD, ScD, author of Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among Whites in the United States

Interview with Ahmad Awada, MD, PhD, author of Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial, and Mark D. Pegram, MD, author of Neratinib in ERBB2-Positive Brain Metastases

Interview with Ruth Etzioni, PhD, author of Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies, and Andrew J. Vickers, PhD, author of Does Prostate-Specific Antigen Screening Do More Good Than Harm? Depends on How You Do It

Interview with Andrew T. Chan, MD, MPH, author of Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer

Interview with Ann H. Partridge, MD, MPH, author of BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer

Interview with Katherine A. Janeway, MD, MSc, author of Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study, and D. Williams Parsons, MD, PhD, author of Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

Interview with Mariana Chavez-MacGregor, MD, MSc, author of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer, and Richard J. Bleicher, MD, author of Time to Surgery and Breast Cancer Survival in the United States

Interview with William N. William Jr, MD, and Scott M. Lippman, MD, author of Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial

Interview with Diana L. Miglioretti, PhD, author of Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status

Interview with Ola Landgren, MD, PhD, author of Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study, and Nikhil C. Munshi, MD, author of Association of Agent Orange With Plasma Cell Disorder: Further Evidence